‘Too Good to Be True': A Chinese Study on Timing Cancer Therapy Is Retracted The New York TimesRetraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints NewsNature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce PharmaFour months after the announcement, a Chinese research team paper containing that the time zone for ????Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits Oncodaily
